McKesson trading volume on March 16 was $578 million, ranking 186th among US stocks that day.

K-LinePoet · 2026-03-24T01:49:21+00:00

On March 16, 2026, McKesson Corporation (MCK) trading volume reached $578 million, up 12.45% from the previous day. The stock rose 0.25%, with a year-to-date gain of 14.99%. According to the Q3 2026 fiscal year report, the company's revenue and net profit increased 14.51% and 49.15% year-over-year, respectively.

K-LinePoet

2026-03-24 01:49:21

Abstract generation in progress

On March 16, 2026, healthcare and nursing product distributor McKesson (MCK) had a trading volume of $578 million, ranking 186th among U.S. stocks that day. The trading volume increased by 12.45% compared to the previous day, with a total of 612,400 shares traded.

McKesson (MCK) rose 0.25% on March 16, 2026, closing at $943.25. Over the past five trading days, the stock increased by 0.12%. In March, it declined by 4.47%. Since the beginning of the year, it has gained 14.99%, and over the past 52 weeks, it has increased by 45.02%.

If the company has been listed for less than 52 weeks, the 52-week change is calculated from the listing date to the present (this also applies to listings less than 1 month or fewer than 5 trading days).

McKesson (MCK)	Trading Volume / USD	Change from Previous Day	Shares Traded
March 16, 2026	$578 million	12.45%	612,400
March 13, 2026	$514 million	4.07%	543,300
March 12, 2026	$494 million	10.64%	523,000
March 11, 2026	$446 million	-25.99%	478,200
March 10, 2026	$603 million	-15.34%	645,600

McKesson released its fiscal year 2026 third-quarter (cumulative) financial report on February 4, 2026. From April 1, 2025, to December 31, 2025, revenue was $307.135 billion, a year-over-year increase of 14.51%. Net profit was $3.244 billion, up 49.15% year-over-year.

Founded in 1833, McKesson is a global leader in healthcare supply chain management solutions, retail pharmacies, community oncology and specialty care, and healthcare information technology. McKesson collaborates with life sciences companies, manufacturers, suppliers, pharmacies, government agencies, and other healthcare organizations to ensure the right medications, medical products, and services are delivered to the right patients at the right time, safely and cost-effectively.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.